Search alternatives:
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
wt decrease » we decrease (Expand Search), a decrease (Expand Search), awd decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
wt decrease » we decrease (Expand Search), a decrease (Expand Search), awd decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
1
-
2
Significant decrease of SMAD4 protein in DBA iPSCs.
Published 2015“…<p>DBA iPSCs (labelled as “<i>RPS19/RPL5</i> mutant” or “<i>RPS19/RPL5</i> mutant-”), the corrected DBA cells (expressing a WT version of the mutated gene, <i>RPL5</i> or <i>RPS19</i>, labelled as “<i>RPS19/RPL5</i> mutant <i>RPS19/RPL5</i>” or “corrected <i>RPS19/RPL5</i> mutant”) and the control GFP cells (expressing GFP, labelled as “<i>RPS19/RPL5</i> mutant GFP”) were cultured and the nuclear and cytoplasmic protein was extracted from iPSCs for western blot analysis, and RNA for q-PCR analysis. …”
-
3
Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs.
Published 2015“…D) Western blot analysis showing slight change of p-SMAD2 level in the nuclear fractions from <i>RPS19</i> mutant compared to WT and the corrected lines. The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
-
4
-
5
-
6
H-MSCs<sup>WT</sup> reduced infarct size and collagen I expression 7 days post-MI.
Published 2014Subjects: -
7
-
8
-
9
-
10
-
11
-
12
-
13
Expression of WT dyskerin can rescue the expression of <i>LGR5</i>, <i>WLS</i> and <i>FRZB</i>.
Published 2015Subjects: -
14
-
15
-
16
-
17
-
18
-
19
GSK343 decreased tumor stemness.
Published 2021“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
-
20